Zobrazeno 1 - 10
of 776
pro vyhledávání: '"Kilty, I."'
Autor:
Riath Al-Samarrai
Publikováno v:
Mail on Sunday; 2/20/2022, p160, 1p
Autor:
Emming S; Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia., Monteleone MM; Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia., Kambara H; Quench Bio, Inc., Cambridge, MA, USA., Starchenko A; Quench Bio, Inc., Cambridge, MA, USA., Alley J; Quench Bio, Inc., Cambridge, MA, USA., Nolan MA; Quench Bio, Inc., Cambridge, MA, USA., Li W; Quench Bio, Inc., Cambridge, MA, USA., Kilty I; Quench Bio, Inc., Cambridge, MA, USA., Schroder K; Institute for Molecular Bioscience, and Centre for Inflammation and Disease Research, The University of Queensland, St. Lucia, Australia. k.schroder@imb.uq.edu.au.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2696, pp. 199-210.
Autor:
Bewley, M.A., Belchamber, K.B., Chana, K.K., Budd, R.C., Donaldson, G., Wedzicha, J.A., Brightling, C.E., Kilty, I., Donnelly, L.E., Barnes, P.J., Singh, D., Whyte, M.K., Dockrell, D.H.
Publikováno v:
Bewley, M A, Belchamber, K B R, Chana, K K, Budd, R C, Donaldson, G, Wedzicha, J A, Brightling, C E, Kilty, I, Donnelly, L E, Barnes, P J, Singh, D & Whyte, M K B & Dockrell, D 2016, ' Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD ', PLoS ONE, vol. 11, no. 9, pp. e0163139 . https://doi.org/10.1371/journal.pone.0163139
PLoS ONE
Bewley, M A, Belchamber, K B R, Chana, K K, Budd, R C, Donaldson, G, Wedzicha, J A, Brightling, C E, Kilty, I, Donnelly, L E, Barnes, P J, Singh, D, Whyte, M K B, Dockrell, D H & COPDMAP 2016, ' Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD ', PLoS ONE, vol. 11, no. 9, pp. e0163139 . https://doi.org/10.1371/journal.pone.0163139
PLoS ONE
Bewley, M A, Belchamber, K B R, Chana, K K, Budd, R C, Donaldson, G, Wedzicha, J A, Brightling, C E, Kilty, I, Donnelly, L E, Barnes, P J, Singh, D, Whyte, M K B, Dockrell, D H & COPDMAP 2016, ' Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD ', PLoS ONE, vol. 11, no. 9, pp. e0163139 . https://doi.org/10.1371/journal.pone.0163139
Pulmonary inflammation and bacterial colonization are central to the pathogenesis of chronic obstructive pulmonary disease (COPD). Defects in macrophage phagocytosis of both bacteria and apoptotic cells contribute to the COPD phenotype. Small molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f5e1cdf1f91ed01a502d9fb84d3a19f
https://www.pure.ed.ac.uk/ws/files/28576749/Whyte_M_Differential_effects....pdf
https://www.pure.ed.ac.uk/ws/files/28576749/Whyte_M_Differential_effects....pdf
Autor:
Porter, JD, Watson, J, Roberts, LR, Gill, SK, Groves, H, Dhariwal, J, Almond, MH, Wong, E, Walton, RP, Jones, LH, Tregoning, J, Kilty, I, Johnston, SL, Edwards, MR
Publikováno v:
Journal of Antimicrobial Chemotherapy
BACKGROUND: Exacerbations of asthma and COPD are triggered by rhinoviruses. Uncontrolled inflammatory pathways, pathogenic bacterial burden and impaired antiviral immunity are thought to be important factors in disease severity and duration. Macrolid
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kojonazarov B; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Sydykov A; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Pullamsetti SS; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany; Department of Lung Development and Remodelling, Max-Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Luitel H; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Dahal BK; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Kosanovic D; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Tian X; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Majewski M; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Baumann C; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Evans S; Pfizer Global Research and Development, Sandwich, United Kingdom., Phillips P; Pfizer Global Research and Development, Sandwich, United Kingdom., Fairman D; Pfizer Global Research and Development, Sandwich, United Kingdom., Davie N; Pfizer Global Research and Development, Sandwich, United Kingdom., Wayman C; Pfizer Global Research and Development, Sandwich, United Kingdom., Kilty I; Pfizer Global Research and Development, Sandwich, United Kingdom., Weissmann N; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Grimminger F; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Seeger W; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany; Department of Lung Development and Remodelling, Max-Planck Institute for Heart and Lung Research, Bad Nauheim, Germany., Ghofrani HA; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany., Schermuly RT; Department of Internal Medicine, Justus-Liebig-University Giessen, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research, Germany. Electronic address: ralph.schermuly@innere.med.uni-giessen.de.
Publikováno v:
International journal of cardiology [Int J Cardiol] 2022 Jun 15; Vol. 357, pp. 152-153. Date of Electronic Publication: 2022 Mar 30.
Autor:
Winkler A; Pfizer, Cambridge, Massachusetts., Sun W; Pfizer, Cambridge, Massachusetts., De S; The Feinstein Institute, Manhasset, New York., Jiao A; Pfizer, Cambridge, Massachusetts., Sharif MN; Pfizer, Cambridge, Massachusetts., Symanowicz PT; Pfizer, Cambridge, Massachusetts., Athale S; Baylor Institute for Immunology Research, Dallas, Texas., Shin JH; Pfizer, Cambridge, Massachusetts., Wang J; Pfizer, Cambridge, Massachusetts., Jacobson BA; Pfizer, Cambridge, Massachusetts., Ramsey SJ; Pfizer, Cambridge, Massachusetts., Dower K; Pfizer, Cambridge, Massachusetts., Andreyeva T; Pfizer, Cambridge, Massachusetts., Liu H; Pfizer, Cambridge, Massachusetts., Hegen M; Pfizer, Cambridge, Massachusetts., Homer BL; Pfizer, Cambridge, Massachusetts., Brodfuehrer J; Pfizer, Cambridge, Massachusetts., Tilley M; Pfizer, Cambridge, Massachusetts., Gilbert SA; Pfizer, Cambridge, Massachusetts., Danto SI; Pfizer, Cambridge, Massachusetts., Beebe JJ; Pfizer, Cambridge, Massachusetts., Barnes BJ; The Feinstein Institute, Manhasset, New York., Pascual V; Baylor Institute for Immunology Research, Dallas, Texas., Lin LL; Pfizer, Cambridge, Massachusetts., Kilty I; Pfizer, Cambridge, Massachusetts., Fleming M; Pfizer, Cambridge, Massachusetts., Rao VR; Pfizer, Cambridge, Massachusetts.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Dec; Vol. 73 (12), pp. 2206-2218. Date of Electronic Publication: 2021 Nov 01.
Autor:
Faherty, Lynne1,2 (AUTHOR), Zhang, William Z.3 (AUTHOR), Salih, Mays M.4 (AUTHOR), Robinson, Elektra K.4 (AUTHOR), Perez, Elizabeth3 (AUTHOR), Kim, Kihwan3 (AUTHOR), Carpenter, Susan4 (AUTHOR), Cloonan, Suzanne M.1,2,3 (AUTHOR) suzanne.cloonan@tcd.ie
Publikováno v:
Respiratory Research. 8/24/2024, Vol. 25 Issue 1, p1-8. 8p.
Autor:
Danto SI; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA. spencer.i.danto@pfizer.com., Shojaee N; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA., Singh RSP; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA., Li C; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA., Gilbert SA; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA., Manukyan Z; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA., Kilty I; Immunology and Inflammation Research Unit, Pfizer Worldwide Research & Development, Cambridge, MA, 02139, USA.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2019 Dec 05; Vol. 21 (1), pp. 269. Date of Electronic Publication: 2019 Dec 05.
Autor:
Belchamber KBR; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Singh R; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Batista CM; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Whyte MK; MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Dockrell DH; MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK., Kilty I; Inflammation and Immunology Research Unit, Pfizer Inc, Cambridge, MA, USA., Robinson MJ; MedImmune, Cambridge, UK., Wedzicha JA; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Barnes PJ; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK., Donnelly LE; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK l.donnelly@imperial.ac.uk.
Publikováno v:
The European respiratory journal [Eur Respir J] 2019 Oct 10; Vol. 54 (4). Date of Electronic Publication: 2019 Oct 10 (Print Publication: 2019).